Loss of intra-islet CD20 expression may complicate efficacy of B-cell-directed type 1 diabetes therapies.
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
    Serreze DV, Chapman HD, Niens M, Dunn R, Kehry MR, Driver JP, Haller M, Wasserfall C, Atkinson MA. Loss of intra-islet CD20 expression may complicate efficacy of B-cell-directed type 1 diabetes therapies. Diabetes. 2011 Nov; 60(11):2914-21.